News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AstraZeneca PLC (AZN) Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial     2/17/2017
Roche (RHHBY) Faces Off With Itself for $9 Billion Breast Cancer Drug Business     2/15/2017
Merrimack (MACK) Halts Phase II HERMIONE Study for Breast Cancer; Further Plans Revealed in January     12/22/2016
Celgene (CELG) Decides to Not Move Forward With Phase III Portion of tnAcity     12/7/2016
NICE U-Turns and Backs Approval of Roche (RHHBY)'s Perjeta for HER2-Positive Breast Cancer     11/22/2016
Puma Biotech (PBYI) Crashes After Diarrhea Risk is Linked to Breast Cancer Drug in Abstract     11/16/2016
Eli Lilly (LLY)'s Breast Cancer Drug Failed to Meet Phase III Goals, But Panel Recommends Continuation of Trial     8/10/2016
FDA Bestows Novartis AG (NVS)'s Breast Cancer Pill With Breakthrough Tag     8/3/2016
Amgen (AMGN) And Allergan (AGN) Biosimilar Found as Effective as Genentech (RHHBY)'s Herceptin     7/21/2016
Galena Biopharma  (GALE) Craters and Discontinues Phase III Breast Cancer Vaccine NeuVax     6/30/2016
ASCO2016: Mylan (MYL)-BioCon (BIOCON.NS)'s Biosimilar Cancer Drug Comparable to Roche (RHHBY)'s Herceptin     6/6/2016
ASCO2016: Immunomedics (IMMU) Breast Cancer Abstract Booted from Conference     6/6/2016
Nektar Therapeutics (NKTR), DAIICHI SANKYO EUROPE GmbH Strike $80 Million+ ONZEALD Pact     6/1/2016
Novartis AG (NVS) Trial Stopped Early on Positive Data, Gets Ready to Take on Pfizer (PFE)'s Ibrance     5/31/2016
AstraZeneca PLC (AZN)'s Fulvestrant Meets Goals in Phase III Study     5/27/2016

News from Around the Web
Sought-After Tesaro (TSRO) Sees A $5 Billion Opportunity For Its Cancer Drug     2/17/2017
Scalp Cooling Device May Help Reduce Hair Loss For Women With Breast Cancer On Chemotherapy, JAMA Reveals     2/15/2017
Biggest Breast Cancer Breakthrough: Map Links Cell Shape And Genes To Disease Outcomes, Institute of Cancer Research in London Study     2/6/2017
Were Women Foolish To Follow Angelina Jolie Into BRCA Cancer Gene Testing?     1/5/2017
Breast Cancer Cells Do Not Like It Spicy, Ruhr-University Study     12/22/2016
How 3 Huge Discoveries in 2016 are Moving Us Closer to a Breast Cancer Cure     10/24/2016
Puma Biotech (PBYI)'s $150 Million Stock Offering May Signal to Investors That Its Breast Cancer Drug is in Trouble     10/20/2016
Mammograms More Likely To Cause Unneeded Treatment Than To Save Lives, Published In BMJ     10/13/2016
Newly Developed: Non-Invasive, Safe Tester For Breast Cancer Diagnosis, Polish Biotech Braster Reveals     10/7/2016
Implant Improves Breast Cancer Survival, University of Michigan Study     9/30/2016
Want A BRCA Test? Some Insurers Require Genetic Counseling First     9/19/2016
Simple Blood Test Could Be Used To Detect Breast Cancer, University of Western Australia Study     9/9/2016
New Platform Hopes To Speed Diagnosis Of Parkinson's Disease And Breast Cancer, Oxford Impedance Diagnostics Reveals     8/1/2016
New Review Concludes Evidence For Alcohol Causing Cancer Is Strong, University Of Otago Study     7/22/2016
Got Dense Breasts? That Can Depend On Who Is Reading The Mammogram, University of Vermont Study     7/19/2016

Press Releases
Myriad Genetics (MYGN)’s Bracanalysis CDx Test Successfully Identified Metastatic Breast Cancer Patients With Improved Outcomes From AstraZeneca PLC (AZN)'s PARP Inhibitor, Olaparib     2/17/2017
TapImmune (TPIV) Advances TPIV 200 Phase II Triple-Negative Breast Cancer Trial After Favorable DSMB Safety Review     2/15/2017
Scalp Cooling Device May Help Reduce Hair Loss For Women With Breast Cancer On Chemotherapy, JAMA Reveals     2/15/2017
ASLAN Reports Positive Top-Line Results For Phase II Clinical Trial Of Varlitinib In Metastatic Breast Cancer     2/9/2017
Biggest Breast Cancer Breakthrough: Map Links Cell Shape And Genes To Disease Outcomes, Institute of Cancer Research in London Study     2/6/2017
NYU Langone Medical Center Release: Changes In Gene Contribute Independently To Breast And Ovarian Cancer     2/1/2017
Volpara Release: Increasing Breast Density Significantly Impacts Breast Cancer Screening Performance     1/30/2017
Cynvenio, Milenia Labs Release: Companies Enter Into Exclusive Distribution Agreement For ClearID Breast Cancer Testing In Mexico     1/26/2017
FUJIFILM Release: FDA Approves The Company's Digital Breast Tomosynthesis Option For ASPIRE Cristalle Digital Mammography System     1/24/2017
Daiichi Sankyo Release: Company Initiates Phase 1/2 Study Of Novel Antibody Drug Conjugate U3-1402 In Patients With HER3-Positive Metastatic Or Unresectable Breast Cancer     1/18/2017
Mylan (MYL) Release: FDA Accepts Biologics License Application (BLA) For Pharma And BioCon (BIOCON.NS)'s Proposed Biosimilar Trastuzumab     1/11/2017
OncoTAb Release: Company Presentation To Highlight Results Of Study On A Blood-Test Based Multi-Modal Screening Strategy For Early Breast Cancer Detection At Biotech Showcase Conference     1/11/2017
G1 Therapeutics Release: Biotech Initiates Three Drug Development Programs In Breast Cancer     1/10/2017
Experimental Biology and Medicine Release: Gleevec: A Possible Therapeutic Drug For Notch And/Or C-Myc Positive Breast Cancer     1/10/2017
Cynvenio Releases Second-Generation ClearID Breast Cancer Blood Test     1/9/2017

//-->